10
Aug
2022
12:30
BST
19:30
SGT
13:30
CEST
Webinar
Edoxaban: ENGAGEing in Individualisation of DOACs
-
Views:
4665
-
Likes:
15
Overview
Direct oral anticoagulants (DOACs) have revolutionised the treatment of venous thromboembolism and atrial fibrillation. By the time edoxaban was approved in 2015, healthcare providers already had a few years of experience with using dabigatran, rivaroxaban and apixaban and determining which is preferred based on patient characteristics. This webinar will review the use of edoxaban, with a focus on its special features in relation to other DOACs and practical tips for its use in clinical practice. This webinar is the third in a series of six webinars from the ISCP focusing on the A to Z of CV Pharmacotherapy. Led by moderators Claire Lew (Singapore) and Ann Leung (Hong Kong), it includes a speaker presentation from Doreen Su-Yin Tan (Singapore) and a discussion from panellists Gheorghe-Andrei Dan (Romania) and Oskars Kalējs (Latvia) that will examine the importance of DOACs, through consideration of real-world examples, live discussions and audience Q&A.
This live webinar is EBAC accredited. 1 CME credit will be granted upon confirmation of successful attendance.
This is an independent activity run by the International Society of Cardiovascular Pharmacotherapy (ISCP). The ISCP has been provided support to develop this webinar by Menarini APAC through an unrestricted educational grant. The supporter has had no influence on the content of the programme or provided any funding to Radcliffe Cardiology.
To see more content from the A to Z of CV Pharmacotherapy series click here.
Faculty:
Doreen Su-Yin Tan
Gheorghe-Andrei Dan
Oskars Kalējs
Claire Lew
Ann Leung
This webinar is supported by
Agenda
Key Learning Objectives
- To evaluate and understand which patients should and should not be prescribed edoxaban and which patients groups might benefit most;
- To determine how edoxaban should be administered and what dosage adjustments and drug interactions need to be noted;
- To analyse special and regional issues that impact the use of this drug;
- To apply evidence-based recommendations to two real world cases.
Target Audience
- Cardiovascular team members - doctors, nurses, pharmacists
- Family physicians
- Internists
- Cardiovascular pharmacotherapy researchers
Faculty Biographies
Doreen Su-Yin Tan
Doreen Tan is an Associate Professor of Clinical & Pharmacy Practice at the National University of Singapore.
Gheorghe-Andrei Dan
Dr Gheorghe-Andrei Dan is Head of Internal Medicine University Clinic, Colentina University Hospital, Bucharest and Head of the Cardiology Department and Diagnostic Cardiovascular Procedures and Arrhythmology Unit – University Hospital Colentina.
Oskars Kalējs
Dr Oskars Kalējs is Professor at the Latvian Centre of Cardiology and Chief of the Arrhythmia Service at Pauls Stradiņš University Hospital, LV.
Claire Lew
Ms Claire Lew is ISCP Governor for Singapore & Senior Pharmacist, Tan Tock Seng Hospital, SG.
Ann Leung
Dr Ann Leung is a lecturer at the University of Hong Kong, Department of Pharmacology and Pharmacy. She is currently the Programme Coordinator of the Master of Clinical Pharmacy and Master of Advanced Pharmacy Programme.